Delivery Order SPE2DB24D2216-SPE2DB25FGNFG
Award Date
3/27/25
Potential Completion Date
3/28/25
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,178.62 firm fixed-price delivery order is for the supply of GEMTESA 75 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of November 1, 2023 and was awarded on October 31, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of GEMTESA 75 MG TABLET 30S, a pharmaceutical product. The fixed-price delivery order is valued at $26,225.55 and has an ultimate completion date of March 17, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $62,693.66, is a Firm Fixed Price Delivery Order for the provision of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has a completion date of June 13, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $8,596.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GEMTESA 75 MG TABLET 30S, a pharmaceutical product, with a completion date of April 1, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, valued at $78,816.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with an ultimate completion date of April 9, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it was not designated as a Set-Aside contract. AmerisourceBergen Drug Corp holds a...
This federal contract award, valued at $6,251.59, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a completion date of January 27, 2025. The contract has a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This federal contract award, valued at $21,627.11, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of GEMTESA 75 MG TABLET 30S, a pharmaceutical product, with a completion date of February 4, 2025. The contract is a Firm Fixed Price Delivery Order, and there was no set-aside designation used. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award is for a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for GEMTESA 75 MG TABLET 30S. The firm-fixed-price contract has a ceiling value of $11,277.99 and an ultimate completion date of April 25, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for $1,556.40. The contract is for the supply of GEMTESA 75 MG TABLET 30S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military treatment...
This federal contract award is for the delivery of GEMTESA 75 MG TABLET 90S to the Defense Logistics Agency (DLA). The $11,323.19 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on July 25, 2024 with a completion date of July 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...